Trial site
Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A.
- 22running trials
- 13closed trials
The trials here
What the 36 trials at this site are about, from their registry records.
- Conditions
- Psoriasis14 trials
- Psoriatic arthritis11 trials
- Type 2 diabetes5 trials
- Rheumatoid arthritis4 trials
- Chronic kidney disease3 trials
- Graves' disease2 trials
- Ankylosing spondylitis1 trial
- Atrial fibrillation1 trial
- Endometriosis1 trial
- Gout1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- and 5 more
- Phase
- Phase 330 trials
- Phase 26 trials
- Status
- Active, not recruiting12 trials
- Completed12 trials
- Recruiting6 trials
- Not yet recruiting4 trials
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Novo Nordisk A/S5 trials
- AbbVie3 trials
- Bristol-Myers Squibb3 trials
- Takeda3 trials
- and 13 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Active, not recruiting
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Psoriasis3 recruiting
- Chronic kidney disease2 recruiting
- Graves' disease2 recruiting
- Psoriatic arthritis2 recruiting
- Type 2 diabetes2 recruiting
- Rheumatoid arthritis1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Active, not recruiting
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026